It's not an issue of the production capacity being a constraint or not; it's a question of whether we have available production capacity right now that is not being put to use.
The answer to this question is “yes”. The other question is, “Why is this?” On this, trying to maintain the system in place will not help to contribute to production capacity.
We have Mr. Sorenson here, but we would have basically the same story from Donald Gerson at PnuVax, for example, who could tell you exactly the same thing. He has the same issues in trying to start producing the vaccine. If we don't have a government that is applying its weight in order to help these businesses and partners, or by producing these vaccines itself through a public manufacturing capacity, basically we're stuck in the situation we are in right now.